Medigen Biotechnology Statistics
Total Valuation
TPEX:3176 has a market cap or net worth of TWD 4.33 billion. The enterprise value is 6.13 billion.
Market Cap | 4.33B |
Enterprise Value | 6.13B |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:3176 has 139.31 million shares outstanding. The number of shares has decreased by -0.00% in one year.
Current Share Class | 139.31M |
Shares Outstanding | 139.31M |
Shares Change (YoY) | -0.00% |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 6.56% |
Owned by Institutions (%) | 4.25% |
Float | 109.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.67 |
PB Ratio | 0.85 |
P/TBV Ratio | 2.73 |
P/FCF Ratio | n/a |
P/OCF Ratio | 193.79 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.71, with an EV/FCF ratio of -219.20.
EV / Earnings | -231.50 |
EV / Sales | 3.78 |
EV / EBITDA | 36.71 |
EV / EBIT | n/a |
EV / FCF | -219.20 |
Financial Position
The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.19.
Current Ratio | 4.69 |
Quick Ratio | 3.77 |
Debt / Equity | 0.19 |
Debt / EBITDA | 5.14 |
Debt / FCF | -35.20 |
Interest Coverage | 0.72 |
Financial Efficiency
Return on equity (ROE) is -0.00% and return on invested capital (ROIC) is 0.18%.
Return on Equity (ROE) | -0.00% |
Return on Assets (ROA) | 0.17% |
Return on Invested Capital (ROIC) | 0.18% |
Return on Capital Employed (ROCE) | 0.34% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.22 |
Inventory Turnover | 1.04 |
Taxes
In the past 12 months, TPEX:3176 has paid 107.25 million in taxes.
Income Tax | 107.25M |
Effective Tax Rate | 100.23% |
Stock Price Statistics
The stock price has decreased by -32.06% in the last 52 weeks. The beta is 0.33, so TPEX:3176's price volatility has been lower than the market average.
Beta (5Y) | 0.33 |
52-Week Price Change | -32.06% |
50-Day Moving Average | 30.05 |
200-Day Moving Average | 34.14 |
Relative Strength Index (RSI) | 50.93 |
Average Volume (20 Days) | 148,551 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:3176 had revenue of TWD 1.62 billion and -26.50 million in losses. Loss per share was -0.19.
Revenue | 1.62B |
Gross Profit | 970.75M |
Operating Income | 19.98M |
Pretax Income | 107.01M |
Net Income | -26.50M |
EBITDA | 169.30M |
EBIT | 19.98M |
Loss Per Share | -0.19 |
Balance Sheet
The company has 2.59 billion in cash and 985.05 million in debt, giving a net cash position of 1.60 billion or 11.49 per share.
Cash & Cash Equivalents | 2.59B |
Total Debt | 985.05M |
Net Cash | 1.60B |
Net Cash Per Share | 11.49 |
Equity (Book Value) | 5.10B |
Book Value Per Share | 12.11 |
Working Capital | 2.92B |
Cash Flow
In the last 12 months, operating cash flow was 22.32 million and capital expenditures -50.30 million, giving a free cash flow of -27.98 million.
Operating Cash Flow | 22.32M |
Capital Expenditures | -50.30M |
Free Cash Flow | -27.98M |
FCF Per Share | -0.20 |
Margins
Gross margin is 59.90%, with operating and profit margins of 1.23% and -1.63%.
Gross Margin | 59.90% |
Operating Margin | 1.23% |
Pretax Margin | 6.60% |
Profit Margin | -1.63% |
EBITDA Margin | 10.45% |
EBIT Margin | 1.23% |
FCF Margin | n/a |
Dividends & Yields
TPEX:3176 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.00% |
Shareholder Yield | n/a |
Earnings Yield | -0.61% |
FCF Yield | -0.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPEX:3176 has an Altman Z-Score of 2.8 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.8 |
Piotroski F-Score | 7 |